Longaeva Partners »

Bridgebio Pharma shares owned by Longaeva Partners

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Longaeva Partners from 13F filings

Historical chart of Longaeva Partners investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Longaeva Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Longaeva Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $14M 188k 74.48

More positions owned by Longaeva Partners

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Space Exploration Techn Corp Class A Com Stk (SPCX)
Goldman Sachs Put Option (GS)
JPMorgan Chase & Co. (JPM)
Select Sector Spdr Tr St Str Care Etf Call Option (XLV)
Bank of America Corporation (BAC)
Pfizer Call Option (PFE)
Boston Scientific Corporation Call Option (BSX)
Fifth Third Ban (FITB)
Huntington Bancshares Incorporated (HBAN)
Moody's Corporation (MCO)
Mettler-Toledo International (MTD)
Lpl Financial Holdings (LPLA)
Us Bancorp Com New (USB)
Morgan Stanley Com New (MS)

View all positions for Longaeva Partners

Top funds holding Bridgebio Pharma

Jupiter Topco
Kohlberg Kravis Roberts & Co
Henderson Group
Farallon Capital Management
BlackRock
Viking Global Investors
Vanguard Capital Management
Vanguard Portfolio Management
Jane Street
UBS Group
Wellington Management Company
State Street Corporation
Two Sigma Investments
Aisling Capital Management
Citadel Advisors

View all funds holding Bridgebio Pharma